Bingyin Shi
-
- Thyroid Cancer Diagnosis and Treatment 17
- Thyroid Disorders and Treatments 15
- Cancer Research top 5%
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 17
- RNA modifications and cancer 15
- Cancer-related gene regulation 14
- Oncology top 10%
- Cancer-related Molecular Pathways 7
- Pathology and Forensic Medicine top 10%
-
- T-cell and B-cell Immunology 6
-
- Diabetes and associated disorders 5
- Journals
- Journal of Clinical Oncology (1 paper)PLoS ONE (1 paper)The Journal of Clinical Endocrinology & Metabolism (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Bingyin Shi
86 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 107
- Endocrinology, Diabetes and Metabolism 460
- Cancer Research 355
- Molecular Biology 1.1k
- Oncology 342
- Pathology and Forensic Medicine 177
Countries citing papers authored by Bingyin Shi
This map shows the geographic impact of Bingyin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingyin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingyin Shi more than expected).
Fields of papers citing papers by Bingyin Shi
This network shows the impact of papers produced by Bingyin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingyin Shi. The network helps show where Bingyin Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bingyin Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 2 | |
| 5 | 2021 | 21 | |
| 6 | 2019 | 1 | |
| 7 | 2019 | 7 | |
| 8 | 2018 | 53 | |
| 9 | 2018 | 40 | |
| 10 | 2018 | 20 | |
| 11 | 2018 | 23 | |
| 12 | 2016 | 1 | |
| 13 | 2016 | 21 | |
| 14 | 2015 | 1 | |
| 15 | 2014 | 33 | |
| 16 | 2013 | 36 | |
| 17 | 2013 | 54 | |
| 18 | 2011 | 5 | |
| 19 | 2011 | 8 | |
| 20 | 2009 | 26 |
About Bingyin Shi
Bingyin Shi is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Molecular Biology, having authored 87 papers that have together received 1.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (17 papers), Thyroid Cancer Diagnosis and Treatment (17 papers), Thyroid Disorders and Treatments (15 papers), RNA modifications and cancer (15 papers), Cancer-related gene regulation (14 papers), Cancer-related Molecular Pathways (7 papers), T-cell and B-cell Immunology (6 papers) and Diabetes and associated disorders (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (460 citations), Cancer Research (355 citations) and Molecular Biology (1.1k citations). Bingyin Shi has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Peng Hou, Meiju Ji, Qi Yang, Haixia Guan, Jing Shi, Demao Yao, Nongyue He, Yiping Qu, Guanjun Zhang and Ya Li. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.